168 related articles for article (PubMed ID: 7788935)
21. Advances in the treatment of neurofibromatosis-associated tumours.
Lin AL; Gutmann DH
Nat Rev Clin Oncol; 2013 Nov; 10(11):616-24. PubMed ID: 23939548
[TBL] [Abstract][Full Text] [Related]
22. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
[TBL] [Abstract][Full Text] [Related]
24. Familial meningioma is not allelic to neurofibromatosis 2.
Pulst SM; Rouleau GA; Marineau C; Fain P; Sieb JP
Neurology; 1993 Oct; 43(10):2096-8. PubMed ID: 8413972
[TBL] [Abstract][Full Text] [Related]
25. Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma.
Evans DG; Lye R; Neary W; Black G; Strachan T; Wallace A; Ramsden RT
J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):764-7. PubMed ID: 10329751
[TBL] [Abstract][Full Text] [Related]
26. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.
Leone PE; Bello MJ; Mendiola M; Kusak ME; De Campos JM; Vaquero J; Sarasa JL; Pestana A; Rey JA
Int J Mol Med; 1998 May; 1(5):889-92. PubMed ID: 9852312
[TBL] [Abstract][Full Text] [Related]
27. Schwannomas and their pathogenesis.
Hilton DA; Hanemann CO
Brain Pathol; 2014 Apr; 24(3):205-20. PubMed ID: 24450866
[TBL] [Abstract][Full Text] [Related]
28. Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2.
Kehrer-Sawatzki H; Udart M; Krone W; Baden R; Fahsold R; Thomas G; Schmucker B; Assum G
Hum Genet; 1997 Jul; 100(1):67-74. PubMed ID: 9225971
[TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.
Wu CL; Thakker N; Neary W; Black G; Lye R; Ramsden RT; Read AP; Evans DG
J Med Genet; 1998 Dec; 35(12):973-7. PubMed ID: 9863591
[TBL] [Abstract][Full Text] [Related]
30. [Diagnostic image (252). A woman with complaints of tinnitus, hearing loss and headache].
te Lintelo MP; Koehler PJ
Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2565. PubMed ID: 16320667
[TBL] [Abstract][Full Text] [Related]
31. The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.
Kehrer-Sawatzki H; Farschtschi S; Mautner VF; Cooper DN
Hum Genet; 2017 Feb; 136(2):129-148. PubMed ID: 27921248
[TBL] [Abstract][Full Text] [Related]
32. Primary tumours of the vestibule and inner ear.
O'Keeffe LJ; Camilleri AE; Gillespie JE; Cairns A; Ramsden RT
J Laryngol Otol; 1997 Aug; 111(8):709-14. PubMed ID: 9327006
[TBL] [Abstract][Full Text] [Related]
33. Identification of three neurofibromatosis type 2 (NF2) gene mutations in vestibular schwannomas.
Sainz J; Figueroa K; Baser ME; Pulst SM
Hum Genet; 1996 Jan; 97(1):121-3. PubMed ID: 8557252
[TBL] [Abstract][Full Text] [Related]
34. Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.
Bassiri K; Ferluga S; Sharma V; Syed N; Adams CL; Lasonder E; Hanemann CO
EBioMedicine; 2017 Feb; 16():76-86. PubMed ID: 28126595
[TBL] [Abstract][Full Text] [Related]
35. NF2 status of meningiomas is associated with tumour localization and histology.
Kros J; de Greve K; van Tilborg A; Hop W; Pieterman H; Avezaat C; Lekanne Dit Deprez R; Zwarthoff E
J Pathol; 2001 Jul; 194(3):367-72. PubMed ID: 11439370
[TBL] [Abstract][Full Text] [Related]
36. [Neurofibromatosis type 2].
Goutagny S; Bouccara D; Bozorg-Grayeli A; Sterkers O; Kalamarides M
Rev Neurol (Paris); 2007 Sep; 163(8-9):765-77. PubMed ID: 17878803
[TBL] [Abstract][Full Text] [Related]
37. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J
Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128
[TBL] [Abstract][Full Text] [Related]
38. PTEN is not altered in sporadic vestibular schwannomas.
Mawrin C; Kirches E; Boltze C; Dietzmann K
Histopathology; 2002 Jun; 40(6):526-30. PubMed ID: 12047763
[TBL] [Abstract][Full Text] [Related]
39. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases.
Zang KD
Cytogenet Cell Genet; 2001; 93(3-4):207-20. PubMed ID: 11528114
[TBL] [Abstract][Full Text] [Related]
40. Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.
Maxwell M; Shih SD; Galanopoulos T; Hedley-Whyte ET; Cosgrove GR
J Neurosurg; 1998 Mar; 88(3):562-9. PubMed ID: 9488313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
